Hoedemaeker RF - Search Results

1

Hoedemaeker RF, Vis AN, Van Der Kwast TH. Hoedemaeker RF, et al. Microsc Res Tech. 2000 Dec 1;51(5):423-9. doi: 10.1002/1097-0029(20001201)51:5<423::AID-JEMT4>3.0.CO;2-4. Microsc Res Tech. 2000. PMID: 11074612 Review.

2

Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer.

Hoedemaeker RF, Rietbergen JB, Kranse R, van der Kwast TH, Schröder FH. Hoedemaeker RF, et al. World J Urol. 1997;15(6):339-45. doi: 10.1007/BF01300181. World J Urol. 1997. PMID: 9436283 Clinical Trial.

3

Prostate cancer detection at low prostate specific antigen.

Schröder FH, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R. Schröder FH, et al. Among authors: hoedemaeker rf. J Urol. 2000 Mar;163(3):806-12. J Urol. 2000. PMID: 10687982 Clinical Trial.

4

Histopathological prostate cancer characteristics at radical prostatectomy after population based screening.

Hoedemaeker RF, Rietbergen JB, Kranse R, Schröder FH, van der Kwast TH. Hoedemaeker RF, et al. J Urol. 2000 Aug;164(2):411-5. J Urol. 2000. PMID: 10893598 Clinical Trial.

5

Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy.

Vis AN, Boerma MO, Ciatto S, Hoedemaeker RF, Schröder FH, van der Kwast TH. Vis AN, et al. Among authors: hoedemaeker rf. Urology. 2000 Oct 1;56(4):617-21. doi: 10.1016/s0090-4295(00)00681-6. Urology. 2000. PMID: 11018617

6

Defining the window of opportunity in screening for prostate cancer: validation of a predictive tumor classification model.

Vis AN, Hoedemaeker RF, van der Kwast TH, Schröder FH. Vis AN, et al. Among authors: hoedemaeker rf. Prostate. 2001 Feb 1;46(2):154-62. doi: 10.1002/1097-0045(20010201)46:2<154::aid-pros1019>3.0.co;2-1. Prostate. 2001. PMID: 11170143 Clinical Trial.

7

Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml).

Vis AN, Hoedemaeker RF, Roobol M, van der Kwast TH, Schröder FH. Vis AN, et al. Among authors: hoedemaeker rf. Prostate. 2001 Jun 1;47(4):252-61. doi: 10.1002/pros.1069. Prostate. 2001. PMID: 11398172 Clinical Trial.

8

Pathologic features of prostate cancer found at population-based screening with a four-year interval.

Hoedemaeker RF, van der Kwast TH, Boer R, de Koning HJ, Roobol M, Vis AN, Schröder FH. Hoedemaeker RF, et al. J Natl Cancer Inst. 2001 Aug 1;93(15):1153-8. doi: 10.1093/jnci/93.15.1153. J Natl Cancer Inst. 2001. PMID: 11481387 Free article. Clinical Trial.

9

The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancer.

Vis AN, Hoedemaeker RF, Roobol M, Schröder FH, van der Kwast TH. Vis AN, et al. Among authors: hoedemaeker rf. Cancer. 2001 Aug 1;92(3):524-34. doi: 10.1002/1097-0142(20010801)92:3<524::aid-cncr1351>3.0.co;2-a. Cancer. 2001. PMID: 11505396

10

Report of the Pathology Committee: false-positive and false-negative diagnoses of prostate cancer.

Van der Kwast TH, Lopes C, Martikainen PM, Pihl CG, Santonja C, Neetens I, Di Lollo S, Hoedemaeker RF. Van der Kwast TH, et al. Among authors: hoedemaeker rf. BJU Int. 2003 Dec;92 Suppl 2:62-5. doi: 10.1111/j.1465-5101.2003.04400.x. BJU Int. 2003. PMID: 14983958 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters